Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05199779 · ClinicalTrials.gov registry record · NA
Single Session Intervention for Building Self-Compassion Habits-RCT
A NA study of Transdiagnostic Psychopathology, sponsored by University of California, Berkeley.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
- 1
- Study location
NCT05199779: Completed NA study of Transdiagnostic Psychopathology, sponsored by University of California, Berkeley.
NCT05199779 is a NA study of Transdiagnostic Psychopathology that has completed, run by University of California, Berkeley. The registered enrollment target is 135 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05199779, a NA study of Transdiagnostic Psychopathology, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will test a single session self-compassion intervention that leverages an ultra-brief contemplative exercise. It will evaluate the effect of this intervention on psychopathology, stress, growth mindset, positive affect, self-compassion and the automaticity of self-compassion, as well as the relationships between these constructs and the automaticity of self-compassion. The participants will be undergraduate students at a large public university.
Primary Outcome
Sum of 20-item, 5-point response scale. Scores can range from 20 to 100 (Higher score means higher compassion for self). Sub-scale items included.
Conditions Studied
Interventions
- BEHAVIORAL Single Session Intervention Leveraging an Ultra-Brief Self-Compassion Exercise
- BEHAVIORAL Finger-Tapping Active Control
Study Locations (1)
California
- University of California at Berkeley - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2022-02-13 |
| Est. Completion | 2022-04-29 |
| Phase | NA |
What the finished NCT05199779 record still lists
NCT05199779 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Transdiagnostic Psychopathology appearing as the primary indexed condition, and to 2 interventions - of which Single Session Intervention Leveraging an Ultra-Brief Self-Compassion Exercise is the first listed.
NCT05199779 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05199779 about?
NCT05199779 is a clinical study titled "Single Session Intervention for Building Self-Compassion Habits-RCT". The study will test a single session self-compassion intervention that leverages an ultra-brief contemplative exercise. It will evaluate the effect of this intervention on psychopathology, stress, growth mindset, positive affect, self-compassion and the automaticity of self-compassion, as well as th...
What is the current status of trial NCT05199779?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2022-02-13. Estimated completion is 2022-04-29.
What conditions does trial NCT05199779 study?
This clinical trial studies the following conditions: Transdiagnostic Psychopathology.
What interventions are being tested in trial NCT05199779?
The interventions under investigation include: Single Session Intervention Leveraging an Ultra-Brief Self-Compassion Exercise (BEHAVIORAL), Finger-Tapping Active Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05199779?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05199779 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05199779's enrollment target sits among peer trials
135 726th of 2000 higher than 1,273 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI